Press releases
RedHill Biopharma Announces Full-Year 2023 Results and Operational Highlights
8 Apr 24
Earnings, Press Releases
RedHill Biopharma Announces $1.25 Million Registered Direct Offering at a Premium to Market Price
2 Apr 24
Offerings, Press Releases
RedHill Announces New USPTO Patent Covering Talicia® Through 2034
11 Mar 24
Press Releases
Nasdaq Stocks Under $1 to Watch Now! VTAK, IVP, ONCO, AKTS, RDHL
31 Jan 24
News, Press Releases